Literature DB >> 20621038

Patient-specific pluripotent stem cells become even more accessible.

Shinya Yamanaka1.   

Abstract

In this issue of Cell Stem Cell, Staerk et al. (2010), Seki et al. (2010), and Loh et al. (2010) each describe the derivation of human iPSCs from peripheral blood. Although seemingly incremental, this advance brings the stem cell field an important step closer to eventual clinical use. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Year:  2010        PMID： 20621038     DOI： 10.1016/j.stem.2010.06.009

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  20 in total

Review 1.  Present and future challenges of induced pluripotent stem cells.

Authors:  Mari Ohnuki; Kazutoshi Takahashi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

2.  Differentiation of mouse iPS cells into ameloblast-like cells in cultures using medium conditioned by epithelial cell rests of Malassez and gelatin-coated dishes.

Authors:  Koki Yoshida; Jun Sato; Rie Takai; Osamu Uehara; Yoshihito Kurashige; Michiko Nishimura; Itsuo Chiba; Masato Saitoh; Yoshihiro Abiko
Journal:  Med Mol Morphol       Date:  2014-10-16       Impact factor: 2.309

3.  Signaling adaptor protein SH2B1 enhances neurite outgrowth and accelerates the maturation of human induced neurons.

Authors:  Yi-Chao Hsu; Su-Liang Chen; Ya-Jean Wang; Yun-Hsiang Chen; Dan-Yen Wang; Linyi Chen; Chia-Hsiang Chen; Hwei-Hsien Chen; Ing-Ming Chiu
Journal:  Stem Cells Transl Med       Date:  2014-04-15       Impact factor: 6.940

Review 4.  Induced pluripotent stem cells as a disease modeling and drug screening platform.

Authors:  Antje D Ebert; Ping Liang; Joseph C Wu
Journal:  J Cardiovasc Pharmacol       Date:  2012-10       Impact factor: 3.105

5.  Blood Derived Induced Pluripotent Stem Cells (iPSCs): Benefits, Challenges and the Road Ahead.

Authors:  Holly N Cukier; Jimmy El Hokayem; Derek M Dykxhoorn
Journal:  J Alzheimers Dis Parkinsonism       Date:  2016-10-25

6.  Generation of induced pluripotent stem cells from human renal proximal tubular cells with only two transcription factors, OCT4 and SOX2.

Authors:  Nuria Montserrat; María José Ramírez-Bajo; Yun Xia; Ignacio Sancho-Martinez; Daniel Moya-Rull; Laia Miquel-Serra; Shenglian Yang; Emmanuel Nivet; Carme Cortina; Federico González; Juan Carlos Izpisua Belmonte; Josep M Campistol
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

Review 7.  Biomaterials Regulate Mechanosensors YAP/TAZ in Stem Cell Growth and Differentiation.

Authors:  Jasmeet Kaur Virdi; Prasad Pethe
Journal:  Tissue Eng Regen Med       Date:  2020-11-24       Impact factor: 4.169

Review 8.  Progress in cell grafting therapy for temporal lobe epilepsy.

Authors:  Ashok K Shetty
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

9.  The current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine.

Authors:  Ana M Martins; Gordana Vunjak-Novakovic; Rui L Reis
Journal:  Stem Cell Rev Rep       Date:  2014-04       Impact factor: 5.739

10.  Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells.

Authors:  Ashley Ulm; Christopher N Mayhew; Jason Debley; Gurjit K Khurana Hershey; Hong Ji
Journal:  J Vis Exp       Date:  2016-03-10       Impact factor: 1.355
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.